Clinical Trials · NCT04431713
Exenatide Once-weekly as a Treatment for Multiple System Atrophy
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- University College, London
- Enrollment
- 50
- Start date
- Sep 2020
- Locations
- 1 site, United Kingdom
- Primary endpoint
- Change in UMSARS Score (Parts I+II) From Baseline